NMRA — Neumora Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Neumora Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS/A	PROSPECTUS/A	PROSPECTUS/A	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	192	409	372	454	308
Net Total Receivables	0.148	0.2	0.919	0.939	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	194	416	388	478	314
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.92	4.04	10.6	6.86	2.92
Long Term Investments
Other Long Term Assets
Total Assets	198	429	426	496	317
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9.37	23.3	23.7	25.1	29.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	10.7	24.7	29.4	27.1	29.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	187	405	397	469	287
Total Liabilities & Shareholders' Equity	198	429	426	496	317
Total Common Shares Outstanding